Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin

(2017) Michael M. Schartner et al.   Scientific Reports

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

(2016) Anna Rickli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

(2016) Frederick S Barrett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders

(2016) Linda Nguyen et al.   PHARMACOLOGY & THERAPEUTICS

Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use

(2016) Charles P. Taylor et al.   PHARMACOLOGY & THERAPEUTICS

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

(2015) Frederick S Barrett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

LSD enhances the emotional response to music

(2015) M. Kaelen et al.   PSYCHOPHARMACOLOGY

The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice

(2014) Theresa M. Carbonaro et al.   PSYCHOPHARMACOLOGY

Psilocybin – Summary of knowledge and new perspectives

(2013) Filip Tylš et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades

(2012) Hannah K. Delille et al.   NEUROPHARMACOLOGY

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

(2012) Chad J. Reissig et al.   PSYCHOPHARMACOLOGY

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

(2012) André Schmidt et al.   PSYCHOPHARMACOLOGY

Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs

(2011) Miguel Fribourg et al.   CELL

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

(2011) José L. Moreno et al.   NEUROSCIENCE LETTERS

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

(2010) Erich Studerus et al.   PLoS One

Dextromethorphan

(2009) Joseph A. Banken et al.   Annals of the New York Academy of Sciences

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines

(2008) J. C. Winter   PSYCHOPHARMACOLOGY

The behavioral pharmacology of hallucinogens

(2007) William E. Fantegrossi et al.   BIOCHEMICAL PHARMACOLOGY